[1]
А. А. Авагимян, “EFFECT OF TRIMETAZIDINE ON MYOCARDIAL KARYOMETRY DURING THE DOXORUBICIN-CYCLOPHOSPHAMIDE MODE OF CHEMOTHERAPY PRESCRIPTION”, МК, vol. 21, no. 2, pp. 25–29, Jun. 2022, doi: 10.24412/2687-0053-2022-2-25-29.